Abstract
Statin therapy is the cornerstone of anti-atherosclerotic treatment, and it considered obligatory in the secondary prevention of atherosclerotic diseases. Rosuvastatin is well-known and efficacious lipid-lowering agent. Generic drugs are more frequently used instead of its ancestors. Generic rosuvastatin forms have been aproved recently to the Central European market, but their safety and efficacy have not been previously examined in cerebrovascular patient populations. Patients and methods: 109 patients with documented ischaemic cerebrovascular events were included in our study. 20 mg generic rosuvastatin significantly decreased total cholesterol (5.47 vs. 3.88 mmol/l, p
| Original language | Hungarian |
|---|---|
| Pages (from-to) | 857-860 |
| Number of pages | 4 |
| Journal | Orvosi Hetilap |
| Volume | 153 |
| Issue number | 22 |
| DOIs | |
| Publication status | Published - Jun 2012 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
A generikus rosuvastatin hatékonyságának vizsgálata cerebrovascularis betegekben. / Szapáry, L.; Fehér, G.
In: Orvosi Hetilap, Vol. 153, No. 22, 06.2012, p. 857-860.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - A generikus rosuvastatin hatékonyságának vizsgálata cerebrovascularis betegekben
AU - Szapáry, L.
AU - Fehér, G.
PY - 2012/6
Y1 - 2012/6
N2 - Statin therapy is the cornerstone of anti-atherosclerotic treatment, and it considered obligatory in the secondary prevention of atherosclerotic diseases. Rosuvastatin is well-known and efficacious lipid-lowering agent. Generic drugs are more frequently used instead of its ancestors. Generic rosuvastatin forms have been aproved recently to the Central European market, but their safety and efficacy have not been previously examined in cerebrovascular patient populations. Patients and methods: 109 patients with documented ischaemic cerebrovascular events were included in our study. 20 mg generic rosuvastatin significantly decreased total cholesterol (5.47 vs. 3.88 mmol/l, p
AB - Statin therapy is the cornerstone of anti-atherosclerotic treatment, and it considered obligatory in the secondary prevention of atherosclerotic diseases. Rosuvastatin is well-known and efficacious lipid-lowering agent. Generic drugs are more frequently used instead of its ancestors. Generic rosuvastatin forms have been aproved recently to the Central European market, but their safety and efficacy have not been previously examined in cerebrovascular patient populations. Patients and methods: 109 patients with documented ischaemic cerebrovascular events were included in our study. 20 mg generic rosuvastatin significantly decreased total cholesterol (5.47 vs. 3.88 mmol/l, p
KW - generic
KW - prevention
KW - statin
KW - stroke
KW - transient ischaemic attack
UR - http://www.scopus.com/inward/record.url?scp=84861751804&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84861751804&partnerID=8YFLogxK
U2 - 10.1556/OH.2012.29390
DO - 10.1556/OH.2012.29390
M3 - Article
C2 - 22641260
AN - SCOPUS:84861751804
VL - 153
SP - 857
EP - 860
JO - Orvosi Hetilap
JF - Orvosi Hetilap
SN - 0030-6002
IS - 22
ER -